4.4 Article

Design and application of a self-evaluation questionnaire for individuals at a high-risk of lung cancer

Journal

THORACIC CANCER
Volume 3, Issue 1, Pages 60-67

Publisher

WILEY
DOI: 10.1111/j.1759-7714.2011.00088.x

Keywords

Application; design; lung cancer; risk factors

Funding

  1. The Eleventh Five-Year Development Plans for Major Projects (Lung Cancer Prevention), Chengdu, China [07YTYB961020]
  2. Chengdu Municipal Bureau of Science and Technology
  3. Chengdu Municipal Bureau of Public Health
  4. Chengdu Municipal Bureau of Public Health and Chengdu Municipal Center for Disease Control and Prevention, China

Ask authors/readers for more resources

Objective: The purpose of this study was to establish a comprehensive evaluation system to assess the risk factors of lung cancer for the general population. Methods: With the method of evidence-basedmedicine, risk factors of lung cancer were identified and their risk assignments were calculated to design the Selfevaluation Scoring Questionnaire forHigh-risk Individuals of Lung Cancer. Studies including more than 10 000 subjects were carried the out to confirm the questionnaire's value. Results: The questionnaire consisted of 15 risk factors and their risk assignments, such as sex, age, smoking, female passive smoking, previous illness histories, exposure to harmful gases, mental depression and genetic susceptibility. In the population application, data from30 lung cancer patients revealed its desired reliability and validity. The next pre-investigation, including 94 patients and 252 controls, confirmed its differentiating power, and encouraged a much larger-scale survey with 2161 subjects to determine the threshold (T) to identify high-risk individuals, the threshold was 116 points. According to this criterion, 1537 high-risk volunteers and 6556 controls were recruited to participate in a 3-year follow-up study from 2007 to 2009. There were 31 cases of lung cancer detected in the high-risk group, with a detection rate of 2.02%, significantly higher than that of the controls (5/6556, 0.08%), indicating an excellent predictive value of the questionnaire. Conclusions: The Self-evaluation Scoring Questionnaire for High-risk Individuals of Lung Cancer was a good means for evaluating the risks of lung cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
Article Oncology

IgG4-related retroperitoneal fibrosis induced by nivolumab and ipilimumab in a patient with non-small cell lung cancer: A case report

Masashi Nishimura, Yoshifumi Kimizuka, Takunori Ogawa, Motohiro Tsuchiya, Yoshiki Kato, Akira Matsukida, Shunya Igarashi, Koki Ito, Yusuke Serizawa, Tomomi Tanigaki, Yuji Fujikura, Yuka Katsurada, Sho Ogata, Akihiko Kawana

Summary: This study reports a case of IgG4-related retroperitoneal fibrosis occurring after chemotherapy. The patient showed improvement after discontinuing immunotherapy and receiving steroid treatment.

THORACIC CANCER (2024)

Article Oncology

Different effects of crizotinib treatment in two non-small cell lung cancer patients with SDC4::ROS1 fusion variants

Yuta Ohishi, Yoko Nakanishi, Yukari Hirotani, Atsuko Suzuki, Tomoyuki Tanino, Haruna Nishimaki-Watanabe, Hiroko Kobayashi, Fumi Nozaki, Sumie Ohni, Xiaoyan Tang, Kentaro Hayashi, Yoshiko Nakagawa, Tetsuo Shimizu, Ichiro Tsujino, Noriaki Takahashi, Yasuhiro Gon, Shinobu Masuda

Summary: This study aimed to investigate the clinicopathological differences and therapeutic response of NSCLC patients with SDC4::ROS1 fusion to crizotinib. The study found that different ROS1 fusion partners may affect the efficacy of crizotinib and patient prognosis. In addition, higher expression levels of ROS1 and pERK1/2 in tumor cells of case 2 may be related to the therapeutic response and prognosis.

THORACIC CANCER (2024)

Review Oncology

Advances in new targets for immunotherapy of small cell lung cancer

Zitong Zheng, Juanjuan Liu, Junling Ma, Runting Kang, Zhen Liu, Jiangyong Yu

Summary: Small cell lung cancer (SCLC) is a highly aggressive malignancy with limited treatment options. Over the past decade, immunotherapy has made progress in the treatment of SCLC, but current immune checkpoint inhibitors have limited benefits for patient survival. Therefore, it is important to explore new targets and develop drugs with novel mechanisms for immunotherapy in SCLC.

THORACIC CANCER (2024)

Article Oncology

A case of a shrunken multilocular mediastinal cyst that developed into thymic carcinoma with lung metastases 13 years later

Kazuto Sugai, Kojiro Nakaoka, Rika Tobita, Shinji Kikuchi, Kei Inoue, Midori Enokido, Moriyuki Kiyoshima

Summary: This article presents a case of multilocular mediastinal cyst leading to the development of thymic cancer. Resection of multilocular anterior mediastinal cysts should be considered due to the challenges in preoperative diagnosis, the potential for coexisting tumors with cysts, and the risk of malignant tumor development.

THORACIC CANCER (2024)